Fluoguide AS (FLUO)

Currency in SEK
36.10
0.00(0.00%)
Closed·
FLUO is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
35.0036.10
52 wk Range
28.0047.80
Key Statistics
Prev. Close
36.1
Open
36.1
Day's Range
35-36.1
52 wk Range
28-47.8
Volume
1.02K
Average Volume (3m)
7.85K
1-Year Change
-9.5238%
Book Value / Share
2.78
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
FLUO Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to drop this year

Fluoguide AS News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Strong Buy

Fluoguide AS Earnings Call Summary for Q2/2026

  • FluoGuide reported H1 2026 net loss of DKK 24.6M with cash/securities of DKK 50M; stock rose 7.4% to $33.4 on clinical progress.
  • FDA approved first U.S. site for high-grade glioma trial with seven more sites near activation; Fast Track designation granted for program.
  • Head and neck cancer interim results delayed to early 2027 due to protocol amendment; low-grade glioma trial enrolled first patient in May.
  • Company expects DKK 11M in tax credits and DKK 61M total liquid assets; plans broader brain tumor strategy rollout in H2 2026.
  • CEO highlighted uPAR targeting as 'holy grail' for brain surgery; aims to improve surgical outcomes by enhancing cancer visualization.
Last Updated: 2026/08/25, 14:34
Read Full Transcript

Earnings

Latest Release
Aug 25, 2026
EPS / Forecast
-0,78 / --
Revenue / Forecast
100K / --
EPS Revisions
Last 90 days

FLUO Income Statement

Compare FLUO to Peers and Sector

Metrics to compare
FLUO
Peers
Sector
Relationship
P/E Ratio
−8.6x−1.3x−0.4x
PEG Ratio
0.310.180.00
Price/Book
12.9x1.8x2.6x
Price / LTM Sales
1,453.4x3.5x3.1x
Upside (Analyst Target)
51.6%260.6%48.9%
Fair Value Upside
Unlock16.9%6.8%Unlock

FluoGuide A/S, a clinical stage biotechnology company, develops drugs for precision cancer surgery in Denmark. The company offers FG001, an urokinase-type plasminogen activator receptor target imaging agent, which is in Phase II clinical trial for the treatment of high-grade glioma and lung, head, and neck cancer; and functions as a photosensitizer, which is in pre-clinical stage for the treatment of brain cancer through photothermal and photodynamic therapies. It has a collaboration agreement with Olympus and ZEISS Medical Technologies for the development of FG001 for tumor imaging and surgical margins assessment for head and neck cancer. The company was incorporated in 2018 and is based in Copenhagen, Denmark.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0,000,00%0,00
Other Institutional Investors
1,36M8,33%49,17M
Public Companies & Retail Investors
14,99M91,67%541,04M
Total
16,35M100,00%590,21M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Linc AB4,17%681 00724 584
A/S Arbejdernes Landsbank4,17%681 00724 584

FAQ

What Is the Fluoguide AS (FLUO) Stock Price Today?

The Fluoguide AS stock price today is 36,10 SEK.

What Stock Exchange Does Fluoguide AS Trade On?

Fluoguide AS is listed and trades on the Stockholm Stock Exchange.

What Is the Stock Symbol for Fluoguide AS?

The stock symbol for Fluoguide AS is "FLUO."

What Is the Fluoguide AS Market Cap?

As of today, Fluoguide AS market cap is 590,21M SEK.

What Is Fluoguide AS's Earnings Per Share (TTM)?

The Fluoguide AS EPS (TTM) is -3,00.

When Is the Next Fluoguide AS Earnings Date?

Fluoguide AS will release its next earnings report on Nov 26, 2026.

From a Technical Analysis Perspective, Is FLUO a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Fluoguide AS Stock Split?

Fluoguide AS has split 0 times.

How Many Employees Does Fluoguide AS Have?

Fluoguide AS has 7 employees.

What is the current trading status of Fluoguide AS (FLUO)?

As of Sep 06, 2026, Fluoguide AS (FLUO) is trading at a price of 36,10 SEK, with a previous close of 36,10 SEK. The stock has fluctuated within a day range of 35,00 SEK to 36,10 SEK, while its 52-week range spans from 28,00 SEK to 47,80 SEK.

What Is Fluoguide AS (FLUO) Price Target According to Analysts?

The average 12-month price target for Fluoguide AS is 54,72 SEK, with a high estimate of 64.2527881 SEK and a low estimate of 45.17769517 SEK. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +51,57% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.